Literature DB >> 6363216

Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules.

D Westaby, W M Melia, B R Macdougall, J E Hegarty, R Williams.   

Abstract

A prospective randomised study to compare the efficacy and complications of injection sclerotherapy carried out at intervals of one week and three weeks up to the time obliteration of varices was achieved, was undertaken in 55 patients (48 cirrhosis, six portal vein thrombosis, one nodular regenerative hyperplasia). The number of courses of injection required for obliteration of the varices was not different in the two groups and despite a shorter time scale for obliteration in the weekly treated patients the frequency with which further episodes of bleeding occurred before that was not significantly less. Mucosal ulceration during the period required for obliteration was observed at endoscopy more frequently in the weekly treated patients but was not associated with a greater frequency of postinjection pain, dysphagia or of long term stricture formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363216      PMCID: PMC1432258          DOI: 10.1136/gut.25.2.129

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

2.  Fibreoptic injection of oesophageal varices.

Authors:  K G Williams; J L Dawson
Journal:  Br Med J       Date:  1979-09-29

3.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

4.  Sclerotherapy of bleeding oesophageal varices by means of endoscopy.

Authors:  K J Paquet; E Oberhammer
Journal:  Endoscopy       Date:  1978-02       Impact factor: 10.093

  4 in total
  17 in total

Review 1.  Long term management of oesophageal varices.

Authors:  S K Sarin
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 2.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  N-butyl-2-cyanoacrylate, iso-amyl-2-cyanoacrylate and hypertonic glucose with 72% chromated glycerin in gastric varices.

Authors:  Reda Elwakil; Mohamed Fawzy Montasser; Sara M Abdelhakam; Wesam A Ibrahim
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

4.  Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules.

Authors:  E Akriviadis; J Korula; S Gupta; Y Ko; S Yamada
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

5.  Variceal sclerotherapy: further progress.

Authors:  P M Smith
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

6.  Omeprazole in the management of sclerotherapy-induced esophageal ulcers resistant to H2 blocker treatment.

Authors:  D Jaspersen; T Körner; W Schorr; C H Hammar
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Injection sclerotherapy for the long-term management of variceal bleeding.

Authors:  D Westaby; R Williams
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

8.  Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding.

Authors:  Sarah Sheibani; Saro Khemichian; John J Kim; Linda Hou; Arthur W Yan; James Buxbaum; Lily Dara; Loren Laine
Journal:  Hepatology       Date:  2016-05-17       Impact factor: 17.425

9.  Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study.

Authors:  S K Sarin; G Sachdev; R Nanda; S K Batra; B S Anand
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

10.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.